Immune imprinting of dengue and Zika viruses: immunological, epidemiological, and clinical consequences (ID Epi Seminar Series)

This hybrid in-person/virtual seminar will be presented by Eva Harris, Professor and Chair of the Division of Infectious Diseases and Vaccinology in the School of Public Health at the University of California, Berkeley. The in-person portion will be held in Kresge G3 and does not require registration. Register for the seminar here.

Dr. Eva Harris is Professor and Chair of the Division of Infectious Diseases and Vaccinology, Director of the Center for Global Public Health, and Chair of the Infectious Diseases and Immunity PhD Program in the School of Public Health at the University of California, Berkeley. She has developed a multidisciplinary approach to study the molecular virology, pathogenesis, immunology, epidemiology, clinical aspects and control of dengue, Zika and chikungunya, the most prevalent mosquito-borne viral diseases in humans. Her work addresses immune correlates of protection and pathogenesis and viral and host factors that modulate disease severity, using in vitro approaches, animal models, and research involving human populations.

Recommended readings

• Katzelnick et al. (2020). Zika virus infection enhances future risk of severe dengue disease
• Zambrana et al. (2023). Primary exposure to Zika virus increases risk of symptomatic dengue virus infection with serotypes 2, 3, and 4 but not serotype 1.